thymic stromal lymphopoietininterleukin (IL)-5IL-4/IL-13COPDChronic obstructive pulmonary diseaseBiologic therapiesSt George's Respiratory Questionnaire
…es targeting interleukin (IL)-5, IL-5 receptor α, IL-4/IL-13 or thymic stromal lymphopoietin in patients with COPD and biomarker-defined T2 inflammation wer…